Regenerex Pharma (RGPX) Operating Leases (2023 - 2025)

Regenerex Pharma (RGPX) has 3 years of Operating Leases data on file, last reported at $392884.0 in Q3 2025.

• Operating Leases for Q3 2025 came in at $392884.0, down 27.19% year-over-year; the trailing twelve-month figure through Sep 2025 was $392884.0 (down 27.19% YoY), and the FY2025 annual result was $495894.0, down 27.27% from the prior year.
• Operating Leases retreated to $392884.0 in Q3 2025 per RGPX's latest filing, from $458858.0 in the prior quarter.
• Over five years, Operating Leases peaked at $803845.0 in Q2 2023 and troughed at $392884.0 in Q3 2025.
• A 3-year average of $603003.3 and a median of $584746.0 in 2024 frame the typical range for Operating Leases.
• On a YoY basis, Operating Leases climbed as much as 21.76% in 2024 and fell as far as 29.39% in 2024.
• A 3-year view of Operating Leases shows it stood at $723497.0 in 2023, then declined by 25.29% to $540528.0 in 2024, then declined by 27.31% to $392884.0 in 2025.
• Business Quant data shows RGPX's Operating Leases at $392884.0 in Q3 2025, $458858.0 in Q2 2025, and $495894.0 in Q1 2025.